United States - English - NLM (National Library of Medicine)

hahnemann laboratories, inc. - cobaltous chloride (unii: evs87xf13w) (cobaltous cation - unii:ai1mr454xg) -

United States - English - NLM (National Library of Medicine)

washington homeopathic products - cobaltous nitrate hexahydrate (unii: 2h2166872f) (cobaltous cation - unii:ai1mr454xg) - to relieve the symptoms of fatigue. indications:  cobaltum nit   fatigue if symptoms persist/worsen or if pregnant/nursing, consult your practitioner.

United States - English - NLM (National Library of Medicine)

hahnemann laboratories, inc. - cobaltous nitrate hexahydrate (unii: 2h2166872f) (cobaltous cation - unii:ai1mr454xg) -

United States - English - NLM (National Library of Medicine)

energique, inc. - glycyrrhiza glabra (unii: 2788z9758h) (glycyrrhiza glabra - unii:2788z9758h), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838), zinc gluconate (unii: u6wsn5sq1z) (zinc cation - unii:13s1s8sf37), potassium phosphate, dibasic (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), iodine (unii: 9679tc07x4) (iodine - unii:9679tc07x4), ph - glycyrrhiza glabra 1 [hp_x] in 1 ml - to speed muscle recovery time and assist the body in replacing spent electrolytes after exertion.** **these statements are based upon traditional homeopathic practice.  they have not been reviewed by the food and drug administration. to speed muscle recovery time and assist the body in replacing spent electrolytes after exertion.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

pekana naturheilmittel gmbh - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), ceanothus americanus leaf (unii: 25b1y14t8n) (ceanothus americanus leaf - unii:25b1y14t8n), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), cobaltous nitrate (unii: 65w79bfd5v) (cobalt - unii:3g0h8c9362), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), manganese acetate (unii: 0v6e9q2i0y) (manganese - unii:42z2k - arsenic trioxide 12 [hp_x] in 50 ml - for relief of minor occasional weakness. application of this homeopathic remedy for the designated usage is exclusively based on homeopathic experience. with severe forms of this disease, a clinically proven therapy is indicated.

United States - English - NLM (National Library of Medicine)

pekana natruheilmittel gmbh - silver nitrate (unii: 95it3w8jze) (silver cation - unii:57n7b0k90a), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), cobaltous nitrate hexahydrate (unii: 2h2166872f) (cobaltous cation - unii:ai1mr454xg), cupric acetate (unii: 39m11xph03) (cupric cation - unii:8cbv67279l), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), potassium carbonate (unii: bqn1b9b9ha) (carbonate ion - unii:7ujq5ope7d), magnesium chloride (unii: 02f3473h9o) (m - homeopathically processed minerals to help reduce minor stress. application of this homeopathic remedy for the designated usage is exclusively based on homeopathic experience. with severe forms of this disease, a clinically proven therapy is indicated.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp), cobaltous gluconate (unii: 26sk597uwv) (cobaltous cation - unii:ai1mr454xg), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), magnesium aspartate (unii: r17x820rol) (magnesium cation - unii:t6v3lhy838), manganese gluconate (unii: 9yy2f980sv) (manganese cation (2+) - unii:h6ep7w5457), phosphorus (unii: 27ylu75u4w) (phosp - viscum album fruiting top 3 [hp_x] in 1 ml - for temporary relief of symptoms related to mineral imbalance in the body including fatigue, dehydration, nervousness and cramping pains.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to mineral imbalance in the body including fatigue, dehydration, nervousness and cramping pains.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

hello life, inc. - antimony trisulfide (unii: f79059a38u) (antimony cation (3+) - unii:069647rpt5), antimony triiodide (unii: 52ze5y9y82) (antimony triiodide - unii:52ze5y9y82), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), silver iodide (unii: 81m6z3d1xe) (silver iodide - unii:81m6z3d1xe), spongilla lacustris (unii: 6sz0g98bhm) (spongilla lacustris - unii:6sz0g98bhm), bromine (unii: sbv4xy874g) (bromine - unii:sbv4xy874g), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell ca - antimony trisulfide 10 [hp_x] in 59 ml - antimon crud, cobaltum nit, nat brom, parathormonum hpus...........................................................................fatigue antimon iod hpus..........................................................................................................................................breathing trouble aqua marina, fucus, ignatia hpus...................................................................................................................constipation arg iod, badiaga, bromium, calc carb, calc iod, ferrum iod, kali iod, thyroidinum hpus.....................................glandular swelling gelsemium, sulphur iod hpus.........................................................................................................................weakness gentianella am, flos, iodium, nat mur, phosphoricum ac hpus...........................................................................depression hydrastis hpus...............................................................................................

United States - English - NLM (National Library of Medicine)

medi-physics, inc. dba ge healthcare - technetium tc-99m exametazime (unii: 3b744ag22n) (technetium tc-99m exametazime - unii:3b744ag22n) - ceretec, when reconstituted with technetium tc 99m exametazime (without cobalt stabilizer solution), is indicated in adults and pediatric patients age 2 to 17 for leukocyte labeled scintigraphy as an adjunct in the localization of intraabdominal infection and inflammatory bowel disease. ceretec, when reconstituted with technetium tc 99m exametazime (with or without cobalt stabilizer solution), is indicated in adults and pediatric patients age 2 to 17 for cerebral scintigraphy as an adjunct in the detection of altered regional cerebral perfusion in stroke. none risk summary limited available data with technetium tc 99m exametazime use in pregnant women are insufficient to inform any drug associated risks for major birth defects and miscarriage. technetium tc 99m exametazime is transferred across the placenta [see data]. animal reproduction studies with technetium tc 99m exametazime have not been conducted. however, all radiopharmaceuticals have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose. if considering technetium tc 99m exametazime administration to a pregnant woman, inform the patient about the potential for adverse pregnancy outcomes based on the radiation dose from technetium tc 99m exametazime and the gestational timing of exposure. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. data human data limited published literature describes tc 99m exametazime crossing the placental barrier and visualization of radioactivity in the fetal liver. no adverse fetal effects or radiation-related risks have been identified for diagnostic procedures involving less than 50 mgy, which represents less than 10 mgy fetal doses. risk summary there are limited data available in the scientific literature on the presence of technetium tc 99m exametazime in human milk. there are no data available regarding the effects of technetium tc 99m exametazime on the breastfed infant or on milk production. exposure of technetium tc 99m exametazime to a breast fed infant can be minimized by temporary discontinuation of breastfeeding [see clinical considerations ]. the developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for ceretec and any potential adverse effects on the breastfed child from ceretec or from the underlying maternal condition. clinical considerations to decrease radiation exposure to the breastfed infant, advise a lactating woman to pump and discard breast milk after the administration of technetium tc 99m exametazime injection or technetium tc 99m exametazime-labeled leukocytes for 12 to 24 hours, where the duration corresponds to the typical range of administered activity, 259 mbq to 925 mbq (7 mci to 25 mci). ceretec is indicated for use in pediatric patients from 2 to 17 years of age for leukocyte labelled scintigraphy and brain scintigraphy. the use of ceretec for leukocyte labelled scintigraphy and brain scintigraphy is supported by extrapolation from clinical effectiveness in adults. the safety and dosing recommendations are based on clinical experience. safety and effectiveness in pediatric patients less than 2 years of age have not been established. clinical studies of ceretec did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. other reported clinical experience has not identified differences in responses between the elderly and younger patients. in general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy. this drug is known to be substantially excreted by the kidney, and radiation exposure may be greater in patients with impaired renal function. a reduction in administered tc 99m can be considered provided an adequate number of leukocytes are administered.

United States - English - NLM (National Library of Medicine)

bioactive nutritional, inc. - boron gluconate (unii: x8p2sy4y7v) (boron - unii:n9e3x5056q), calcium gluconate (unii: sqe6vb453k) (calcium cation - unii:2m83c4r6zb), chromium gluconate (unii: v236zvr3rl) (chromic cation - unii:x1n4508kf1), cobaltous gluconate (unii: 26sk597uwv) (cobaltous cation - unii:ai1mr454xg), copper gluconate (unii: rv823g6g67) (cupric cation - unii:8cbv67279l), ferrous gluconate (unii: u1b11i423z) (ferrous cation - unii:gw89581owr), magnesium gluconate (unii: t42nad2khc) (magnesium cation - unii:t6v3lhy838) - boron gluconate 6 [hp_x] in 1 ml - to speed recovery time after extreme exertion. to speed recovery time after extreme exertion.